The TRUQAP dosing schedule was designed to reduce the risk of side effects.
TRUQAP is taken 4 days in a row, followed by 3 days not taking TRUQAP, each week.
The recommended starting dosage of TRUQAP is 400 mg two times each day, for a total daily dose of 800 mg.
TRUQAP is available in a blister pack for select doses.
Pick your starting day to see your recommended TRUQAP schedule
Select the day of your first dose on the calendar below to reveal your weekly TRUQAP schedule.
Not an actual patient.
Take TRUQAP exactly as your doctor tells you to, as your doctor may adjust your dose based on your personal treatment plan. Do not change your dose or stop taking TRUQAP unless your doctor tells you to.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TRUQAP may affect the way other medicines work, and other medicines may affect how TRUQAP works.
Know the medicines you take. Keep a list of them to show your doctor, nurse, or pharmacist when you get a new medicine.
Store TRUQAP in original packaging at room temperature between 68 °F to 77 °F (20 °C to 25 °C).
Throw away (discard) TRUQAP after 45 days if the tablets are not kept in the original packaging.
TRUQAP comes in child-resistant packaging.
Fulvestrant is an injectable hormone therapy that your doctor will administer on a specific schedule. Each dose is 500 mg.
In the clinical trial, people received fulvestrant on day 1 and day 15 for cycle 1. Then, they received fulvestrant on day 1 for the following cycles. Each cycle was 28 days. Your doctor will follow the recommended fulvestrant dosing information in the fulvestrant Prescribing Information.
If you miss a dose of TRUQAP, you may still take it within 4 hours from the time you usually take it. If it has been more than 4 hours after you usually take your dose, skip that dose. Take the next dose at your usual time. Do not take 2 doses at once to make up for a missed dose.
Swallow whole Swallow TRUQAP tablets whole with water. Do not chew, crush, or split the tablets.
Do not take damaged tablets Do not take any tablets that are broken, cracked, or that look damaged.
Take with or without food TRUQAP can be taken with or without food.
Avoid grapefruit You should not drink grapefruit juice or eat grapefruit during treatment with TRUQAP.
Don’t double up If you vomit after taking a dose, do not take another dose. Take your next dose at your usual time.
Accompanying medication For women who have not reached menopause, your doctor will also prescribe a medicine called a luteinizing hormone-releasing hormone (LHRH) agonist. For men, your healthcare provider may prescribe an LHRH agonist to take with TRUQAP and fulvestrant.

Not an actual patient.

Not an actual patient.
With TRUQAP, you can choose the best day of the week to start
Learn more about
TRUQAP
Discover how
TRUQAP can help
Important Safety Information about TRUQAP® (capivasertib) tablets
ExpandDo not take TRUQAP if you have had a severe allergic reaction to TRUQAP or are allergic to any of the ingredients of TRUQAP.
Before you take TRUQAP, tell your healthcare provider about all your medical conditions, including if you:
Females who are able to become pregnant:
Males with female partners who are able to become pregnant should use effective birth control during your treatment with TRUQAP and for 4 months after the last dose. If your female partner becomes pregnant, tell your healthcare provider right away.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TRUQAP may affect the way other medicines work, and other medicines may affect how TRUQAP works. Know the medicines you take. Keep a list of them to show your healthcare provider or pharmacist when you get a new medicine.
TRUQAP may cause severe side effects, including:
Your healthcare provider may tell you to decrease your dose, temporarily stop your treatment, or completely stop your treatment with TRUQAP if you get certain serious side effects.
The most common side effects of TRUQAP include nausea, tiredness, vomiting, mouth sores and changes in certain blood tests.
These are not all the possible side effects of TRUQAP. Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
TRUQAP is a prescription oral medicine used in combination with the medicine fulvestrant to treat adults who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that is advanced or that has spread to other parts of the body (metastatic), with an abnormal “PIK3CA”, “AKT1”, or “PTEN” gene, and whose disease has progressed on or after endocrine therapy.
Your healthcare provider will test your cancer for an abnormal “PIK3CA”, “AKT1”, or “PTEN” gene to make sure that TRUQAP is right for you.
It is not known if TRUQAP is safe and effective in children.
Please see full Prescribing Information, including Patient Information for TRUQAP.
You may report side effects related to AstraZeneca products.